Jeff Yant

Jeff Yant is a seasoned Executive Director specializing in Biosimilars Operations at Amgen, where they have held various leadership roles since 2011, most recently as the Executive Director of Biosimilars Process Development and Operations. They began their career as a Postdoctoral Research Fellow at the Salk Institute from 1997 to 1999. Jeff holds a B.A. in Biology from the University of California, Santa Cruz, and a PhD in Cell Biology and Experimental Pathology from the University of London. After a successful career at Amgen, Jeff has retired and expressed gratitude for their time at the company.